Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Health › 'Unreasonable delay' in spotting cancer in patient who later died
Health

'Unreasonable delay' in spotting cancer in patient who later died

'Unreasonable delay' in spotting cancer in patient who later died
BBC Scotland Thursday 20 August 2026, 10:12 UTC 1 min read
Key Points

A watchdog has told a Highland medical practice to apologise to the patient's family.

A watchdog has told a Highland medical practice to apologise to the patient's family.
Highland (ORG)
Originally published by BBC Scotland Read original →

Related Stories

Curran to have groin surgery as England Test return put on hold

Sam Curran: England all-rounder to undergo groin surgery as Test return put on hold Sam Curran made to wait for first Test appearance in five years as he undergoes groin surgery; Surrey all-rounder ruled out for the rest of the home season but team-mate Will Jacks in contention for Sri Lanka white-ball series after appendix surgery Thursday 20 August 2026 11:18, UK Sam Curran's hopes of a Test comeback have been put on hold as he undergoes surgery on a groin injury. The Surrey all-rounder...

Sky Sports Football 21m ago

Are eggs safe to eat? Your salmonella questions answered

The UK Health Security Agency (UKHSA) has recently declared a national outbreak of salmonella food poisoning after one person died and hundreds more fell ill with the bug.

BBC Health Extra 28m ago

Are eggs safe to eat? Your salmonella questions answered

The UK Health Security Agency (UKHSA) has recently declared a national outbreak of salmonella food poisoning after one person died and hundreds more fell ill with the bug.

BBC Health 28m ago

How does Moderna’s new mRNA cancer vaccine work?

How does Moderna’s new mRNA cancer vaccine work? Melanoma is the most aggressive form of skin cancer causing about 2,600 deaths a year in the UK - Bookmark - CommentsGo to comments A personalised vaccine given in combination with a drug has been shown to stop tumors returning in skin cancer patients. The experimental mRNA cancer drug, called intismeran, which is personalised for each patient, was developed by pharmaceutical companies Merck and Moderna.

The Independent UK 39m ago